Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Capital Expenditures (2019 - 2026)

Immatics (IMTX) posted Capital Expenditures of -$1.1 million for Q4 2025, up 10.98% sequentially from -$1.3 million in Q3 2025, and up 36.88% YoY from -$824903.9 in Q4 2024.

Analysis

Immatics (IMTX) Capital Expenditures (2019 - 2026) Analysis & Trends

Immatics has reported Capital Expenditures for 7 years, with the latest figure at -$1.1 million in Q4 2025.

  • Quarterly Capital Expenditures rose 36.88% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.2 million (up 58.95% YoY) and the FY2025 annual result came in at -$7.4 million, up 57.93% from the prior year.
  • Capital Expenditures improved to -$1.1 million in Q4 2025 per IMTX's latest filing, from -$1.3 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $56.3 million in Q4 2023 and troughed at -$11.6 million in Q2 2023.
  • A 5-year average of $386663.4 and a median of -$1.6 million in 2025 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 545.09% in 2022, then slumped 1248.09% in 2023.
  • Over 5 years, Capital Expenditures stood at -$2.1 million in 2021, then jumped by 545.09% to $9.3 million in 2022, then surged by 504.3% to $56.3 million in 2023, then slumped by 103.18% to -$1.8 million in 2024, then soared by 36.88% to -$1.1 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$1.1 million, -$1.3 million, and -$1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Immatics 1.17 Bn 711.21 Mn - -1.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.01 Mn
Mar 31, 2026 -893,278.93
Dec 31, 2025 -1.13 Mn
Sep 30, 2025 -1.27 Mn
Jun 30, 2025 -1.62 Mn
Mar 31, 2025 -3.23 Mn
Dec 31, 2024 -1.79 Mn
Sep 30, 2024 -3.08 Mn
Jun 30, 2024 -2.82 Mn
Mar 31, 2024 -9.97 Mn
Dec 31, 2023 -10.00 Mn
Sep 30, 2023 -7.08 Mn
Jun 30, 2023 -11.64 Mn
Mar 31, 2023 -4.63 Mn
Dec 31, 2022 -2.40 Mn
Sep 30, 2022 -1.44 Mn
Jun 30, 2022 -863,248.86
Mar 31, 2022 -1.30 Mn
Dec 31, 2021 -2.09 Mn
Sep 30, 2021 -1.61 Mn